NOLC1

Nucleolar and coiled-body phosphoprotein 1 · Q14978 · NOLC1 on Sugi Atlas →

0 patent compounds predicted against NOLC1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NOLC1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma PHASE2COMPLETED
INCB018424 in Patients With Advanced Hematologic Malignancies PHASE2COMPLETED
PCM1-JAK2 in Therapy Related Neoplasms nanUNKNOWN
Implication of Long Non-coding RNA CCDC144NL-AS1/Micro RNA-143-3p Axis Expression Level as Novel Signature in Colorectal Cancer nanCOMPLETED
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 nanUNKNOWN
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
The Etiology and Progression of Brain Tumors nanCOMPLETED
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy nanCOMPLETED
Genomic Study of Congenital Malformation nanUNKNOWN
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease nanCOMPLETED
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Biomarker in Tissue Samples From Patients With Ewing Sarcoma nanCOMPLETED
H19 in Acute Lymphoblastic Leukemia. nanUNKNOWN
Genetics of Neonatal Encephalopathy and Related Disorders nanRECRUITING
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma nanUNKNOWN
Study of Skeletal Disorders and Short Stature nanCOMPLETED
IPSC Repository of Pediatric Cardiovascular Disease nanRECRUITING
The Relation of Microtubule-Associated Protein 2 and Cell Migration nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Comparative 2-D Tumor Analysis in Familial Gliomas nanCOMPLETED
Genes of Hypertension in African Americans nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NOLC1 binder may also engage these)

ProteinNameSimilarity
P41777 1.000 P41777 →
E9Q5C9 1.000 E9Q5C9 →
Q5XXA7 0.983 Q5XXA7 →
Q56WH4 0.981 Q56WH4 →
Q6P4K1 0.979 Q6P4K1 →
Q24595 0.979 Q24595 →
Q7Z4V5 0.979 Q7Z4V5 →
Q3UMU9 0.978 Q3UMU9 →
Q7XTT4 0.977 Q7XTT4 →
Q9NLA3 0.976 Q9NLA3 →
Q9EPJ0 0.976 Q9EPJ0 →
Q32N87 0.976 Q32N87 →
Q80XU3 0.976 Q80XU3 →
Q8C551 0.976 Q8C551 →
Q58CQ0 0.976 Q58CQ0 →
Q29S11 0.975 Q29S11 →
Q9H1E3 0.975 Q9H1E3 →
Q9ERH4 0.974 Q9ERH4 →
Q5I034 0.973 Q5I034 →
Q96C57 0.973 Q96C57 →
Q9VLK2 0.973 Q9VLK2 →
P16039 0.973 P16039 →
Q925G1 0.973 Q925G1 →
Q52KI8 0.973 Q52KI8 →
Q61937 0.973 Q61937 →
A6QLA6 0.973 A6QLA6 →
Q9LZR5 0.972 Q9LZR5 →
Q8LJS2 0.972 Q8LJS2 →
Q96B01 0.972 Q96B01 →
O08784 0.972 O08784 →